chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My skin is burning diffusely, primarily my legs. It feels similar to getting burned when talking something out of the oven. I?m also having diffuse joint and muscle pain that is at least a 6 on the 0-10 pain scale. I have taken ibuprofen and my Cymbalta with limited relief. Cool air helps decrease the overall burning sensation but does not take it away.
Pt received VZV 9/28/10 pt/Mo states about 2 hr after receiving vaccine back of (L) arm started hurting, turned red & swollen - warm to touch. No fever/no resp problems. Back of arm still warm, swollen & red today. Recommended taking ADVIL/warm/cold compresses.
Pt received Menactra vaccine 2/27/2006. Pt reports that within 1 hour started feeling dizzy, weak persisted. No fever or respiratory symptoms seen in office. Next day reported lightheadedness, weakness, nausea day before. Ongoing headache and dizziness. Exam /// /// 2/28/06. No intervention.
Pt recv vax on 2/5/99; on 2/13/99 pt exp chicken pox-like lesions, fever (102), rhinorrhea, sore throat, lesions in pharynx; tx=acetaminophen & ibuprofen
Felt "goose egg" size lump under left armpit.  States lump soft.  Lump migrated down to abdomen over the week.  Also had significant bruising and swelling upper Left arm deltoid region.  No fever or pain.  Just discomfort.
Administration of expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine) had resolved. Not Provided    For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was reported.  It was reported that the patient had no adverse event.   Most recent FOLLOW-UP information incorporated above includes: On 12-Nov-2021: Follow up document received contains no newinformation
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. The patient demographics were not reported. There was no information reported on patient's medical history and concomitant medications. On 28-JUL-2014, the patient was vaccinated with PNEUMOVAX 23 Product lot# H021941, dose .5ml (millilitre), intramuscularly that expired on 11-JUL-2014. No adverse effects were reported. There was no product quality complaint involved. The outcome of the event was unknown. Additional information has been requested.
Systemic: Chills-Medium, Systemic: Fever-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium
12/16/04- Manufacturer called for follow up info on inadvertent dosing . May have increased risk of side effects. Studies showed no increased raised of SE's - see attached. MD conctacted to report and concurred with manufacturer studies. T/c to mother, message left to return call to HD.
Woke up at 3am with intense pain in armpit and overall body aches and weakness.  Headache, nausea and vomiting. Discovered enlarged lymph nodes in right armpit and groin. All symptoms continue at time of report including severe fatigue and dizziness.
Pericarditis with pericardial effusion. Treatment: Pericardiocentesis, Colchicine, Aspirin, Ibuprofen, Omeprazole Symptoms began (syncopal episode, retrosternal chest heaviness and aching worse with inspiration, fever, chills, lymphadenopathy for a for 9 days following vaccination) Outcome: Patient discharged home after 3 day hospitalization. Currently feeling better at 1 week follow up.
Fever , Headache , Elevated LFT ,  Thrombocytopenia , Renal Failure
R deltoid with erythema, mildly inflamed with induration, per pt. it already subsided.
Pt states her arm felt weak and had difficulty moving or lifting her arm. Pt RTC today and her arm is red, warm and swollen.
Patient stated she sought medical treatment on 10/18/2011 and event was diagnosed as basal ganglia ischemic stroke. She wasn't sure event was related to vaccines she received but wanted to let someone know she may have had a bad reaction. Symptom onset, duration and immediate treatment measures unknown to reporter. Patient received prescriptions for plavix 75mg daily and Lipitor 20mg daily. Pt declined to pick up Lipitor as of 10/25/11 but rx is now ready for pick-up on 10/27/11. Pt was to see neurologist on 10/26/11.
Received Tdap and VZV x 1 days ago, developed arm soreness and low grade fever 100.
Patient describes myalgias and arthralgias in multiple joints.  It has been persistent despite looking for other signs and symptoms .  Can be severe at times including waking her up.  Autoimmune markers are negative.  Steroids with some relief.
Severe incapacitating headache lasting 4 hours 24 hr after headache resolved  developed loss of taste and smell 10 months later, still without sense of taste or smell ( current status)
Approximately two hours after the vaccination, I began to experience dizziness and nausea.  Shortly after this, I noticed what appeared to be small scratches near the injection site.  I was also experiencing muscle soreness and pain all down the arm in which I received the injection during this time.  In order to treat the pain, I began taking acetaminophen every four hours.  While this helped, it did not fully correct the problem.  The day following the injection at around 3pm, I noticed that what had appeared to be scratches the previous day now seemed to have developed into a blotchy rash which has been growing steadily worse since that time.  I have been taking Benadryl to help combat these symptoms, but this rash now covers the area from the top of my shoulder half-way down to my elbow on that arm.  This is the situation as it now stands.
fitfull inconsoleable crying began w/in 1 hr of DTP, cont alternating cont & constant crying for approx 4 hrs;
Pt recvd 2 doses of Engerix-B & 2nd dose was administered 10AUG92; 21AUG92 pt exp dizziness & muscle soreness in arm;
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Treatment medication were not reported.   This case was linked to MOD-2021-395985.
I received my J&J vaccine on 04-05-2021 at 11am and on 04-6-2021 around 6pm I experienced a plugged white ear. The sound in my right ear was completely deformed, I had muffled hearing. I saw an ENT doctor,   on 04-07-2021 at 4pm and he performed an audiology test but by that time my hearing had degraded. I have cohesive hearing loss, age related and my hearing has worsened since last appointment. My symptoms lasted less than 24 hours and I did not receive medicine treatment. On the other hand, I also had secondary symptoms to my left ear, similar to what I experienced in my right ear. I experienced a pulsating drum beat hearing to my left ear and I also did not receive care or treatment. These symptoms lasted temporarily and again I did not receive any medicine for my right and left ear.
Pt developed raised, pruritic lesions to face, trunk and extremities within 48 hours of receiving vaccination series. Symptoms lasted at least 5 days before medical attention received. Pt had moved from out of the country 2 days prior to vaccinations series received. Evaluated by MD on 11/2/06 prescribed calamine lotion.
ten minutes after received vaccines. pt felt dizziness, diaphoric and extremely cold. BP 64/40, pulse 55. Pt felt better after OJ given. Pt has vagus reaction. At 4:30 pm, BP 88/59 p 60. Pt is feeling better. A&Ox3. D/C pt home.
The first night (Tuesday 2/9), I was tired.  The next morning (Wednesday 2/10), I started with a migraine and was nauseous all day.  About 4:30 pm (26 hours later), I started with a fever that ran until Friday morning(2/12).  I also had an intense itchy area on the back of my neck/left side and stomach(Wednesday2/10-Thursday2/11).  On Thursday, I began having an intense pain in my left breast which I still have today 2/19).  I saw my physician on Wednesday, 2/17.
Client received the Pfizer Covid-19 Vaccine (Lot #EW0167 Exp. 08/2021) at 1:51 PM. Approximately 10 minutes after receiving her first dose the patient fainted from her chair in the observation area.  Patient did not strike her head.  EMT and other nurses responded and sat the patient upright and began treatment.  Patient was A&O X3, immediately after fainting.  Patient was assisted to the gravity bed and vitals were taken, see below.  Patient stated that she felt better almost immediately after laying in the gravity bed. Vital signs are as follows: 1400- BP: 100/80, O2: 98%, P: 80, Res: 18; 1405-  BP: 106/74, O2: 98%, P:96, Res: 18; 1410- BP: 110/70, O2: 99%, P: 90, Res: 18; 1415- BP: 110/70, O2: 99%, P: 87, Res: 18; 1420- BP: 112/70, O2: 99%, P: 86, Res: 18; 1425- BP: 110/70, O2: 99%, P: 96, Res: 18.Patient's vitals improved over time after laying down.  Patient was accompanied by her mother who was outside at the time of her fainting.  Patient has a history of fainting after injections and getting blood drawn.  Patient and Patient's mother felt comfortable after 30 minutes of observation to leave the vaccination site and return home.  Client declined EMS transport. Patient and Patient's mother were instructed to seek medical attention if symptoms worsened or if symptoms returned. Patient left the facility in good condition with a steady gait.
Rash covering my upper arm that is swollen, hot to touch, itches. Aching arm, neck and back pain.
This spontaneous report was received from a licensed practical nurse refers to a patient of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On 17-OCT-2016, the patient was vaccinated with improperly stored (16.2 C for 8 hours) doses of M-M-R II (lot # M015931, expiry date 30-MAR-2018, dose, dose number, vaccination site, route unspecified). There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a nurse practitioner concerning a patient who in July 2011 "one year ago" was vaccinated with the first dose of GARDASIL (dose, route and lot # not provided) and on 13-JUL-2012 received the second dose of GARDASIL (dose, route and lot # not provided). The nurse wanted to know when the third dose should be given or if the series would need to be restarted. Additional information has been requested.
Red Rash on both my Cheeks; Bad Headache; Croupy Cough; This is a spontaneous report from a contactable consumer (patient herself). A 63-years-old female patient BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0158; Expiration Date: unknown) via an unspecified route of administration on 24Apr2021 11:15 (at the age of 63-years-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. Medical history included thyroid disorder from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (TIROSINT) taken for thyroid disorder. It was reported that, patient had a shot of vaccine on Saturday afternoon and at night on 24Apr2021 16:00 she developed like a croupy cough and then she had the cough next day on 25Apr2021 she had bad headache. She was feeling better now but she did not go to work. She just wanted to take rest. She enquired that this was normal to develop like a croupy cough or was that having a reaction to the shot or not. She finally took a Tylenol (as a treatment) for headache and her headache went away. She just get worried about taking pills. Patient did get a rash on her cheeks and she got like red rash on both her cheeks on her face on an unspecified date. The outcome of croupy cough and red rash on both my cheeks was unknown while headache was resolved on 26Apr2021.  No follow-up attempts are needed. No further information is expected.
Myalgias, arthralgias, chills, fever starting 10 hours after injection, lasting 3 hours until taking ibuprofen which reduced symptoms after about 45 minutes.
Diagnosed with Right PCA Infarct. Sudden vision issue in left visual area of each eye.
Shingles, beginning treatment with VALACYCLOVIR 3x daily for 7 days.  12 Norco tablets 5/325 for pain, Zofran for nausea.
Patient presented to Health Center after receiving COVID-19 vaccine at Health Center, and going back to work site. He stated when he got to work, he began feeling hot, dizzy, nauseous, and pruritic. Vitals stable. He denied chest pain, difficulty breathing. Pt given IM Benadryl 12.5 mg in office and oral hydration w/ water. He was monitored for about 30 minutes, and said pruritus had resolved, but he felt tired.  EMS called to transport pt to ED. Pt called by Health Center staff about 2 hours later to see how he was doing. He stated he was on his way home as he had been discharged from ED and told to monitor symptoms.
there was only a 2-inch diameter spot on the right cheek that was still numb.; felt dizziness a few minutes after the vaccine.; cheeks started to tingle about 10-15 minutes after the vaccine; The tingling spread to the rest of my face, then turned to numbness.; The roof of my mouth also became numb; throat started to feel scratchy and bizarre.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 05Apr2021 at 14:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included rosacea and allergy to shellfish. Concomitant medications included metronidazole (METROCREAM), riboflavin, magnesium oxide, magnesium citrate and tanacetum parthenium (MIGRELIEF), glucosamine sulfate sodium chloride (DONA GLUCOSAMINE) and calcium gluconate and calcium (MANUFATURER UNKNOWN), all started from an unknown date for unspecified indication. The patient previously took codeine and experienced allergy to it. Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 14:45, 10-15 minutes after the vaccination, the patient experienced dizziness, cheeks started to tingle, the tingling spread to the rest of the face, then turned to numbness and the roof of the mouth also became numb. About two hours after the vaccination, the patient experienced throat started to feel scratchy and bizarre. The symptoms started to subside after about 4.5 hours. After 6 hours, the patient experienced a 2-inch diameter spot on the right cheek that was still numb. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with Benadryl 50 mg and the patient was prescribed with EpiPen by the ER staff. The clinical outcome of the events dizziness, cheeks started to tingle, the tingling spread to the rest of the face, then turned to numbness and the roof of the mouth also became numb, throat started to feel scratchy, bizarre and 2-inch diameter spot on the right cheek was recovered on 05Apr2021 at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient called pharmacy on 6/20/22 complained that her left arm is still hurting for 3 weeks now contributing it to the vaccine.
Explosive diarrhea for days following vaccines. Went to ER and was just advised to follow up w/PCP. All SX's resolved on their own within 1 week.
Initial unsolicited report received from a pharmacist on 12-Feb-2018. This case involves a 65-year-old female patient who was vaccinated with 0.5 ml single dose of IMOVAX POLIO (Batch number: N1G5IIM, expiry date and dose series was not reported) intramuscularly in left deltoid muscle on 01-Feb-2018. The patient also received a dose of ACTHIB, PREVNAR, ENGERIX-B and TENIVAC (Batch number, expiry date, dose in series and route of administration were not reported) in different thighs and other deltoid on 01-Feb-2018. The patient had history of cancer but had no known allergy. Concomitant medication was not reported. On 11-Feb-2018, ten days following the vaccination, the patient experienced arm pain from elbow to collarbone, with pain moving arm. It was also reported that patient was about to see physician for follow up. Relevant lab tests and corrective treatment was not reported. Outcome of the event was not recovered. List of documents held by sender: none.
Tingling sensation in my fifth digit that radiates up to my arm; This is a spontaneous report from a contactable physician, the patient. This 28-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (lot number: EK5730), intramuscularly in the left arm on 23Dec2020 at 12:00 (at the age of 28-years-old) as a single dose for COVID-19 vaccination. It was unknown whether the patient received any other vaccine within 4 weeks prior to the vaccine. Medical history included asthma from an unknown date and unknown if ongoing. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included escitalopram oxalate (LEXAPRO). On 24Dec2020 at 06:00, the patient experienced tingling sensation in her fifth digit that radiates up to her arm. No therapeutic measures were taken as a result of the events. The clinical outcome of the tingling sensation was not resolved. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Hives on forehead, around the eyes, behind ears; Felt burning; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on an unknown date in Feb2021 at 09:30 (at the age of 60-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on an unknown date in Feb2021 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received pseudoephedrine (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. On 12Feb2021 at 09:45 (as reported in source document), 4 hours after the 1st dose of vaccination, the patient started developing hives on his forehead, around the eyes, behind ears. They felt burning and were about nickel size and was lasted 4 to 5 days. After 2nd dose, the patient had the same allergic reactions, but it started 30 minutes after vaccination. The patient had to stay longer at the clinic under medical supervision, and a doctor follow up his case. Hives lasted about 4 days, and occasionally reappear without known reason. The patient took Benadryl. The events resulted in doctor/other health care professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with diphenhydramine hydrochloride (BENADRYL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events  hives on his forehead, around the eyes, behind ears and they felt burning and were about nickel size was resolved with sequelae on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Initial side effects of red arm with some swelling and itching, 99.14 temp day 2, much improved with some itching day 3, day 4 showed rash splotches at arms/legs/back, etc., day 5 show 2 small rash areas---otherwise all seems resolved.
pt c/o being dizzy, fell to knees, then to ground; pt lost consciousness for approx 5 seconds; had bloody rt nostril, hit chin; determined to be a vaso vagal episode;
This case was reported by a pharmacist and described the occurrence of injection site pain in a 52-year-old female patient who received SHINGRIX. Previously administered products included SHINGRIX (refer case: US2018GSK085969). In March 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain and adverse event. On an unknown date, the outcome of the injection site pain and adverse event were unknown. It was unknown if the reporter considered the injection site pain and adverse event to be related to SHINGRIX. Additional information was reported as follows: This case was reported by the patient's husband. The age at vaccination was not reported. The patient experienced local injection site symptoms. This case has been linked with the case US2018GSK085969, US2018GSK085941 and US2018GSK061147, reported by the same reporter. The reporter agreed to receive follow up from GlaxoSmithKline.
Information has been received from a health professional concerning an approximately 8 year old male who in May 2000, was vaccinated with varicella virus vaccine live (Oka/Merck). In 2007, the patient developed a case of chicken pox. A product quality complaint was not reported. Follow up information from the health professional indicated that there was no additional information to provide.
Worst asthma attack in decades.; Difficulty breathing.; Wheeze.; This is a spontaneous report from a contactable consumer (patient). This 67-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8732) via an unspecified route of administration in the left arm on 05Apr2021 at 08:30 (at 67-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. Prior to vaccination the patient was not diagnosed with COVID-19 and had not received any vaccines in the 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received ibuprofen from an unknown date for an unknown indication and experienced allergy; and previously received the first dose of BNT162B2 (lot number EN6708) in the left arm on 15Mar2021 at 08:00 (at 67-years-old) for COVID-19 immunisation. On 05Apr2021 at 17:00 the patient experienced the worst asthma attack in decades, difficulty breathing, and wheezing. The events required a doctor's appointment and albuterol. The clinical outcomes of the events were not recovered. Since vaccination the patient had not been tested for COVID-19.